Tags: nanomedicine

Description

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials. More information on Nanomedicine can be found here.

Resources (41-60 of 189)

  1. Illinois 2011 NanoBiophotonics Summer School: Dr. Naash - Collaboration

    21 Jan 2012 | | Contributor(s):: Muna Naash

  2. Illinois Nano EP Seminar Series Spring 2011: Interfacing Engineering, Biology, and Medicine at the Micro and Nano Scale

    13 Dec 2011 | | Contributor(s):: Rashid Bashir

    In this talk, we will present an overviewof our work in Silicon-Based BioMEMS and Bionanotechnology and discuss the state of the art and thefuture challenges and opportunities. We will review a range of projects in our group focused towardsdeveloping rapid detection of biological entities and...

  3. KIST/PU Advances in detection systems for biology: Classifying signals from fluorescence and scatter

    08 Dec 2011 | | Contributor(s):: J. Paul Robinson

    Biology-driven advances in photonic detection systems have been dramatic in the last several years. Three specific aspects are of particular interest: molecular detection, cellular detection, and whole-organ or small-animal imaging. Each area of study requires specific probes, detectors, and...

  4. KIST/PU Nanostructured Heparin Derivatives as an Angiogenesis Inhibitor

    07 Dec 2011 | | Contributor(s):: Youngro Byun

    Although low molecular weight heparin (LMWH) has been known to regulate angiogenesis, tumor growth and metastasis, the administration of heparin for treating cancer is limited in clinical application due to its unsatisfactory therapeutic effects and a strong anticoagulant activity, which induces...

  5. KIST/PU 6th Annual Symposium: High Impact Research to Society

    07 Dec 2011 |

    In 2006, the South Korean Ministry of Science and Technology selected the KIST and Purdue team project from 20 international research proposals submitted to examine how to learn more about the molecular makeup of diseases.

  6. KIST/PU The Professor’s Challenge: To commercialize or not, that is the question?

    06 Dec 2011 | | Contributor(s):: J. Paul Robinson

    Outline:Outline the Professors DilemmaShow what the normal criteria for research project direction isDiscuss the Corporate perspectiveDiscuss an example of failed innovationDemonstrate how time can impact an innovative ideaConclusions

  7. KIST/PU Designing a Research Program Around Unmet Clinical Needs

    06 Dec 2011 | | Contributor(s):: Alyssa Panitch

  8. KIST/PU Theragnosis – A New Paradigm of Personalized Medicine

    06 Dec 2011 | | Contributor(s):: Ick Chan Kwon

    Companion Diagnosis, based on pharmacogenomics, has been recognized as one of most important key representatives of personalized medicine. However, Companion Diagnosis does not provide any clues in developing new ways of therapeutics but it only provides a best choice of drugs based on given...

  9. Illinois BioNanotechnology Seminar Series Fall 2011: Precisely Size Controlled Drug-silica Nanoconjugate for Cancer Therapy

    05 Dec 2011 | | Contributor(s):: Li Tang

    Drug delivery nanomedicine, exemplified by micelles and nanoparticles roughly in the size range of 1-200 nm, have attracted much interest in the past 2-3 decades as alternative modalities for cancer treatment. The size of these drug delivery vehicles has been strongly correlated with their in...

  10. Illinois BioNanotechnology Seminar Series Fall 2011: Directed Blood Vessel Growth Using an Angiogenic Microfiber/Microparticle Composite Patch

    05 Dec 2011 | | Contributor(s):: Ross J DeVolder

    Therapeutic angiogenesis has emerged as a promising strategy to treat various acute and chronic vascular diseases, and to enhance tissue repair and regeneration. Common revascularization therapies include the administration of angiogenic factors, such as vascular endothelial growth factor (VEGF)....

  11. Illinois BioNanotechnology Seminar Series Fall 2011: Deconvolving Stiffness in MEMS Pedestal Cell Mass Measurements

    05 Dec 2011 | | Contributor(s):: Elise Corbin

    The complex relationships between a cell's behavior and the physical properties of both itself and its environment have long been of interest. Specifically, the understanding the mechanisms through which a cell's physical properties influence cell growth, cell differentiation, cell cycle...

  12. BME 695L Special Lecture 4: Atomic Force Microscopy (AFM) for Nanomedical Systems (cells and nanoparticles)

    02 Dec 2011 | | Contributor(s):: Helen McNally

    Guest lecturer: Helen McNally

  13. BME 695L Special Lecture 3: In vivo Model Systems to Study Nanomedical Approaches to Cancer Detection and Intervention

    02 Dec 2011 | | Contributor(s):: Deborah W Knapp

    Guest lecturer: Deborah Knapp.

  14. BME 695L Lecture 15: GMP and Issues of Quality Control Manufacture of Nanodelivery Systems

    02 Dec 2011 | | Contributor(s):: James Leary

    See references below for related reading.15.1      Overview15.1.1    What does cGMP mean?15.1.2    Why GMP? Controlling processes means more predictable...

  15. BME 695L Lecture 16: FDA and EPA Regulatory Issues

    02 Dec 2011 | | Contributor(s):: James Leary

    See references below for related reading.16.1      Introduction and overview16.1.1    How does the FDA think about nanomedical systems?16.1.2    The 2006 Nanotechnology Task Force16.2      Some...

  16. BME 695L Lecture 12: Assessing Drug Efficacy and Nanotoxicity at the Single Cell Level

    22 Nov 2011 | | Contributor(s):: James Leary

    See references below for related reading.12.1      Introduction to measures of efficacy for nanomedicine12.1.1    for evaluation purposes, does structure/size reveal function?12.1.2    nanomedical treatment at the single cell...

  17. BME 695L Lecture 13: Designing Nanomedical Systems (NMS) for In-vivo Use

    22 Nov 2011 | | Contributor(s):: James Leary

    See references below for related reading.13.1      Bringing in-vivo considerations into NMS design13.1.1    the in-vitro to ex-vivo to in-vivo paradigm         13.1.1.1 In-vitro - importance of choosing...

  18. BME 695L Lecture 14: Designing and Testing Integrated Nanomedical Systems

    22 Nov 2011 | | Contributor(s):: James Leary

    See references below for related reading.14.1      Introduction to integrated designs14.1.1    “Total design” but there is some order in the design process14.1.2    A brief outline of the total design...

  19. BioNanotechnology and Nanomedicine Lecture 25: Force Traction Microscopy

    16 Nov 2011 | | Contributor(s):: Javid Mohammed Ali

    BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology provides an introduction to basic concepts of nanotechnology in mechanobiology and in cancer. This is a highly interdisciplinary field of research where knowledge from various disciplines is presented and integrated....

  20. Illinois BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology Lecture 19: How can you tell if a cell is cancerous?

    14 Nov 2011 | | Contributor(s):: Catherine J. Murphy

    Lecture by Catherine Murphy.